AgeX Therapeutics, Inc.
AMEX: AGE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange Arca
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Eun-Jae Park CPA
- Employees
- 4
- Headquarters
- Alameda, United States
- IPO year
- 2018
- Market cap
- $27.8M
- Website
- https://www.agexinc.com
Loading AGE…
Loading profile data…Frequently asked questions about AGE
What does AgeX Therapeutics, Inc. (AGE) do?
AgeX Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to pioneering and commercializing groundbreaking therapies that address human aging and degenerative conditions. The company's developmental pipeline features several promising cell-based therapeutic candidates: AGEX-BAT1: A cell therapy designed to manage various age-relate...
Where does AGE trade?
AgeX Therapeutics, Inc. (AGE) trades on the New York Stock Exchange Arca.
What sector is AGE in?
AgeX Therapeutics, Inc. (AGE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of AgeX Therapeutics, Inc.?
Eun-Jae Park CPA is the chief executive officer of AgeX Therapeutics, Inc. (AGE).
Where is AgeX Therapeutics, Inc. headquartered?
AgeX Therapeutics, Inc. is headquartered in United States.
Does AGE pay a dividend?
AgeX Therapeutics, Inc. (AGE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AGE go public?
AgeX Therapeutics, Inc. (AGE) completed its initial public offering in 2018.